HELP Helus Pharma Inc. Common Stock
XNAS
10.40
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
HELP
$10.40
—
Key stats
$10.40
- 52-Week Range
- $3.76 – $15.15
- YTD
- +34.54%
- IV Rank (30D)
- 100.0
- Straddle Price
- $4.30
- P/C Vol Ratio
- 0.99
- Market Cap
- $0.7B
- Open
- $10.08
- Day Range
- $10.06 – $10.90
- Volume
- 1,033,739
- Prev Close
- $10.19
Fair Value
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.96% |
| Beta vs SPY | 1.83 |
| Cost of Equity (CAPM) | 15.04% (VRP-adj) |
| WACC | 15.07% |
| Volatility Risk Premium | +143.5pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +3.0% |
| DCF Horizon | 5 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.03 (applied to P/E, EV/EBITDA, P/S) |
| Quality Score | 0/6 — cyclical/struggling (5y DCF) |
| SMA 50 | $12.06 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $11.04 |
| Bollinger Width / SMA20 | 224.3% (drives anchor stability) |
| Net Debt | $0.0B |
Peers used for multiples: ABBV, ANRO, ATAI, CMPS, DFTX, NBIX, NRXP, RLMD
Blended Fair Value
—
Deviation
—
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | |
| Peer EV/EBITDA | n/a | 0% | |
| Peer P/B | n/a | 0% | median 3.9× · 5 peers |
| Peer P/S | n/a | 0% | median 7.8× · 3 peers |
| Market Anchor (SMA50) | $12.06 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | $11.37 | 0% | 8 strikes · skew +0.23 |
As of 2026-10-27 · updated
Related
About
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834) · industry map
- Exchange
- XNAS
- Market Cap
- $0.7B
- Employees
- 50
- List Date
- 2020-11-10
- CIK
- 0001833141
- Next Earnings
- 2026-11-12
- EPS Forecast
- ($0.67) (1 est.)
- Homepage
- https://www.helus.com
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional in…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '26 | Avg |
|---|---|---|
| Jan | -14.36% | -14.36% |
| Feb | 6.99% | 6.99% |
| Mar | -36.93% | -36.93% |
| Apr | 6.41% | 6.41% |
| May | -11.65% | -11.65% |
| Jun | 40.94% | 40.94% |
| Jul | 23.44% | 23.44% |
| Aug | 45.91% | 45.91% |
| Sep | 5.95% | 5.95% |
| Oct | -13.01%* | -13.01% |
| Nov | -- | -- |
| Dec | -- | -- |
| Total | 27.11% | 27.11% |
* Only 1 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $11.04
SMA 50: $12.06
SMA 200: $7.66
Current: $10.36
EMA 12: $10.74
EMA 26: $11.19
MACD: -0.4467 | Signal: -0.0565
BEARISH
ADX (14): 14.92
RANGE
+DI: 20.43
−DI: 22.03
Momentum Oscillators
RSI (14): 41.61
NEUTRAL
Stoch %K: 15.84
Stoch %D: 21.22
Williams %R: -82.87
Volume & Volatility
BB Upper: $12.41
BB Lower: $9.67
NEUTRAL
OBV: 27,025,924
Vol SMA 20: 1,474,620
Vol ROC: -55.81%
ATR: $0.90
True Range: $0.84
HV 20: 63.9%
HV 30: 74.1%
HV 60: 89.3%
Data Summary
Data Points: 204
Last Updated:
Date Range: 2026-01-05T00:00:00 – 2026-10-26T00:00:00
AI Analysis
Here is my comprehensive analysis of HELP stock:
Executive Summary
Overall Assessment: BEARISH (Confidence Level: 6/10)
Key Drivers:
- Technical indicators suggest a bearish momentum, with MACD indicating a potential sell signal
- High volatility and beta indicate higher risk
- Options market signals mixed sentiment, but with a slight bullish bias
Primary Risks:
- Continued decline in stock price due to bearish momentum
- Volatility could lead to significant losses if not managed properly
Investment Thesis: HELP's recent performance has been marred by bearish momentum and high volatility. While the options market suggests some caution, the overall trend appears to be downward.
Recent News Sentiment Impact: None available due to lack of recent news headlines.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): Bearish
- Medium-term (1-3 months): Bearish
- Long-term (3-12 months): Neutral
Support/Resistance Levels:
- SMA 20: $5.00 (resistance)
- EMA 12: $4.76 (support)
Momentum Signals:
- RSI interpretation: Neutral, with a reading of 43.72 indicating no clear trend
- MACD signal: Bearish, with a histogram value of -0.16 indicating a potential sell signal
- Bollinger Bands position: Squeeze, indicating consolidation and potentially higher volatility
Volume Analysis:
- Volume SMA 20: 898771.45 (decreasing volume suggests market exhaustion)
- On-Balance Volume (OBV): -7944740.31 (indicating decreasing buying pressure)
News & Sentiment Analysis
Recent Headlines Summary: None available due to lack of recent news headlines.
Sentiment Assessment: Neutral, as there is no recent news data to analyze.
Catalyst Identification: No upcoming events or earnings releases that could impact the stock price in the near term.
Market Narrative: The absence of recent news headlines and mixed options market signals suggest a neutral market narrative, with no clear catalysts driving the stock price.
Risk & Volatility Assessment
Risk Interpretation:
- Beta: 3.09 (highly volatile compared to SPY)
- Alpha: -1.53 (underperforming the broader market)
Volatility Regime:
- Current vs historical volatility levels: Higher than average, indicating increased risk
Options Market Signals:
- IV Rank: 69.3% (Medium), suggesting historically high volatility
- Current IV: 212.5%
- Expected Move: $0.77 (27 DTE), indicating a potential move in the near term
Downside Protection:
- Support levels: SMA 20 at $5.00 and EMA 12 at $4.76
- Risk management considerations: Consider stop-loss orders or position sizing strategies to manage risk in this highly volatile market.
Market Context & Positioning
Sector Performance:
- HELP is outperforming the broader sector, with a relative strength index of 0.46
Institutional Activity:
- Volume patterns suggest institutional interest, but it's not clear if this activity is buying or selling pressure
Correlation Analysis:
- R-squared interpretation: Correlated with the broader market (0.93), indicating higher volatility and potential for larger price swings
Relative Valuation:
- Position within trading range: Neutral, as there is no recent news data to analyze.
Key Levels & Action Items
Critical Price Levels:
- SMA 20 at $5.00 (resistance)
- EMA 12 at $4.76 (support)
Breakout/Breakdown Levels:
- Bollinger Bands upper boundary at $5.74
- Lower boundary at $4.25
Time-Sensitive Catalysts: None available due to lack of recent news headlines.
Risk Management:
- Consider stop-loss orders or position sizing strategies to manage risk in this highly volatile market.
- Monitor the options market for potential trading opportunities, but exercise caution given the bearish momentum and high volatility.
Generated
News
All HELP news →
HELP Options Activity & IV Rank
HELP IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 208.2%
7-DTE IV: —
Expected Move: $4.30
7-DTE Move: $4.30
Days to Exp: 25 (2026-11-20)
Options Flow
Call Volume: 235
Put Volume: 232
P/C Volume: 0.987
NEUTRAL
Call OI: 6,399
Put OI: 12,617
P/C OI: 1.972
Total OI: 19,016
ATM Options Pricing
ATM Call: $2.35
ATM Put: $1.95
Call %: 22.6%
Put %: 18.8%
Chain Summary
Chain Volume: 1,565
Chain OI: 64,459
Last Updated: 10/26/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 38th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
38%
vs own history
GEX tilt
+0.68
OI-weighted, today
Vanna tilt
+0.75
δ-sensitivity to IV
Charm tilt
-0.71
δ-decay vs time
Vanna tilt +0.75: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.71: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 8 ATM contracts, 13k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
as of Oct 26 · No data
30 DTE / 10d
100%
+55.6
pts
EXTREME
as of Oct 26 · ATM 202.6% / Wing 258.2%
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)100.0HighOct 26
Straddle Price (30 DTE)$4.30Oct 26
Beta Analysis
Risk Metrics
Beta: 2.3236
Alpha: 44.74%
Correlation: 0.3380
R-Squared: 11.4%
Stock Volatility: 89.3%
Market Volatility: 13.0%
Analysis Details
Benchmark: SPY
Data Points: 203
Period: 252 trading days
Data Points: 203
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own HELP
4 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $17.4M | #1213 of 3716 | +9.0% | 13F | |
| Citadel Hedge fund Ken Griffin | $4.1M | #2257 of 6285 | -29.2% | 13F | |
| Point72 Hedge fund Steve Cohen | $704K | #1568 of 1945 | +440.8% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $99K | #2998 of 4729 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
HELP Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
9 filers$8.27M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $2.66M | 32.20% | 2026-06-30 |
| 2 | Simplex Trading, LLC Custodian | $1.78M | 21.52% | 2026-06-30 |
| 3 | GROUP ONE TRADING LLC Custodian | $1.11M | 13.39% | 2026-06-30 |
| 4 | Citadel Advisors LLC Custodian | $795.84K | 9.62% | 2026-06-30 |
| 5 | DIADEMA PARTNERS LP | $661.00K | 7.99% | 2026-06-30 |
| 6 | JPMorgan Chase & Co Custodian | $550.40K | 6.65% | 2026-06-30 |
| 7 | Millennium Management LLC Custodian | $330.50K | 4.00% | 2026-06-30 |
| 8 | Jane Street Group, LLC Custodian | $326.53K | 3.95% | 2026-06-30 |
| 9 | Persistent Asset Partners Ltd | $56.25K | 0.68% | 2026-06-30 |
6 filers$2.11M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $1.04M | 49.05% | 2026-06-30 |
| 2 | JPMorgan Chase & Co Custodian | $550.40K | 26.03% | 2026-06-30 |
| 3 | Citadel Advisors LLC Custodian | $250.52K | 11.85% | 2026-06-30 |
| 4 | Jane Street Group, LLC Custodian | $129.56K | 6.13% | 2026-06-30 |
| 5 | GROUP ONE TRADING LLC Custodian | $111.71K | 5.28% | 2026-06-30 |
| 6 | Simplex Trading, LLC Custodian | $35.03K | 1.66% | 2026-06-30 |
HELP Insider Trading (Form 4)
Latest: 2026-10-01Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Greg Cavers | Chief Financial Officer | Buy (P) | +3,000 | $12.91 | $38.7K | EDGAR |
| 2026-10-01 | Eric H. L. So | Director | Award (A) | +248,000 | — | EDGAR | |
| 2026-10-01 | Paul Glavine | Chief Growth Officer | Award (A) | +248,000 | — | EDGAR | |
| 2026-09-21 | Michael Halstead | Chief Executive Officer | Buy (P) | +100,000 | $13.47 | $1.35M | EDGAR |
| 2026-09-11 | Paul Glavine | Chief Growth Officer | Buy (P) | +100,000 | $12.47 | $1.25M | EDGAR |
| 2026-09-11 | Eric H. L. So | Executive Chair | Buy (P) | +100,000 | $12.39 | $1.24M | EDGAR |
| 2026-09-11 | Paul Glavine | Chief Growth Officer | Buy (P) | +100,000 | $12.47 | $1.25M | EDGAR |
| 2026-09-10 | Eric H. L. So | Executive Chair | Buy (P) | +100,000 | $12.09 | $1.21M | EDGAR |
| 2026-09-10 | Paul Glavine | Chief Growth Officer | Buy (P) | +100,000 | $11.78 | $1.18M | EDGAR |
| 2026-09-09 | Paul Glavine | Chief Growth Officer | Buy (P) | +90,000 | $11.59 | $1.04M | EDGAR |
| 2026-09-09 | Eric H. L. So | Executive Chair | Buy (P) | +95,000 | $11.80 | $1.12M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
HELP Insider Holdings
4 insiders · @ $10.36
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Paul Glavine | Chief Growth Officer | 4,981,132 | $51.60M | $4.72M | 5 | 2026-10-01 |
| 2 | Eric H. L. So | Executive Chair | 4,766,630 | $49.38M | $3.57M | 4 | 2026-10-01 |
| 3 | Michael Halstead | Chief Executive Officer | 168,568 | $1.75M | $1.35M | 1 | 2026-09-21 |
| 4 | Greg Cavers | Chief Financial Officer | 128,937 | $1.34M | $38.7K | 1 | 2026-10-01 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
HELP Board & Officers
As of SEC filings through Oct 26, 2026Directors 8
- Eric H. L. So · since Sep 1, 2026
- Paul Glavine · listed since Oct 2026
- Amir Inamdar · since Oct 13, 2026
- Eric Hoskins · since Oct 13, 2026
- Freda C Lewis-Hall · since Oct 13, 2026
- Grant Froese · since Oct 13, 2026
- Mark Lawson · since Oct 13, 2026
- Theresa Firestone · since Oct 13, 2026
Officers 4
- Michael Halstead · Chief Executive Officer · since Sep 17, 2026
- Greg Cavers · Chief Financial Officer · since Sep 29, 2026
- Paul Glavine · Chief Growth Officer · since Aug 31, 2026
- Eric H. L. So · Executive Chair · since Sep 1, 2026
Changes in the last 10 years (12)
| Oct 13, 2026 | Theresa Firestone became a director |
| Oct 13, 2026 | Mark Lawson became a director |
| Oct 13, 2026 | Grant Froese became a director |
| Oct 13, 2026 | Freda C Lewis-Hall became a director |
| Oct 13, 2026 | Eric Hoskins became a director |
| Oct 13, 2026 | Amir Inamdar became a director |
| Oct 1, 2026 | Paul Glavine first listed as a director in an SEC filing |
| Sep 29, 2026 | Greg Cavers became Chief Financial Officer |
| Sep 17, 2026 | Michael Halstead became Chief Executive Officer |
| Sep 1, 2026 | Eric H. L. So became a director |
| Sep 1, 2026 | Eric H. L. So became Executive Chair |
| Aug 31, 2026 | Paul Glavine became Chief Growth Officer |
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
4 ETFs hold HELP
4 shown · $2.65M total exposure · 0.01% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | PSIL AdvisorShares Psychedelics ETF | Nport | 4.35% | $1.9M | — | 2026-06-30 |
| 2 | ONEQ Fidelity Nasdaq Composite Index ETF | Fidelity | 0.00% | $316,899 | $10.7B | 2026-10-23 |
| 3 | GWX State Street® SPDR® S&P® International Small Cap ETF | SPDR (State Street) | 0.03% | $302,107 | $896.9M | 2026-10-23 |
| 4 | QQQS Invesco NASDAQ Future Gen 200 ETF | Invesco | 0.49% | $100,066 | — | 2026-10-24 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
—
TTM Revenue
—
TTM Net Income
—
TTM Op. Cash Flow
—
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
3.46M
SI % of Float
6.92%
Days to Cover
1.74
Short Vol Ratio
28.2%
Free Float
50.07M
Float %
100.0%
Short interest 2026-09-30 • Short volume 2026-10-26 • Float 2026-04-02